Takeda Pharma AS - Company Review
Takeda Pharma AS - Company ReviewSummary
Takeda Pharma A/S (Takeda), formerly Nycomed Danmark ApS, a subsidiary of Takeda Pharmaceutical Company Ltd, is a drug company that offers prescription drugs, OTC drugs and pharmacy brands. The company offers product in therapeutic areas of oncology, CNS, iron deficiency anemia, pain, COPD, respiratory, cardiovascular disease, osteoporosis, colds and vitamins. Its pain products comprise kodimagnyl DAK, ipren, pamol, and cold products include granon, noskapin DAK, zymelin, hexokain, bromhexine breast drops, daxas, and others. The company operates product development, marketing and sales, administration, international departments of law/patent, business and IT, packing and storage. Takeda is headquartered in Taastrup, Denmark.
This comprehensive company report of Takeda Pharma AS provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.